Thoracic Oncology Clinical Trial Eligibility Criteria and Requirements Continue to Increase in Number and Complexity Sandra Garcia, BS, Ajit Bisen, MD, Jingsheng Yan, PhD, Xian-Jin Xie, PhD, Suresh Ramalingam, MD, Joan H. Schiller, MD, David H. Johnson, MD, David E. Gerber, MD Journal of Thoracic Oncology Volume 12, Issue 10, Pages 1489-1495 (October 2017) DOI: 10.1016/j.jtho.2017.07.020 Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
Figure 1 Median number of eligibility criteria over time. Journal of Thoracic Oncology 2017 12, 1489-1495DOI: (10.1016/j.jtho.2017.07.020) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions
Figure 2 Mean number of eligibility criteria by category over time. CV, cardiovascular; Heme, hematologic; Pulm, pulmonary; GI, gastrointestinal; Neuro, neurologic; Inflamm, inflammatory; Endo, endocrine; Meds, medications; Admin, administrative. Journal of Thoracic Oncology 2017 12, 1489-1495DOI: (10.1016/j.jtho.2017.07.020) Copyright © 2017 International Association for the Study of Lung Cancer Terms and Conditions